智通财经APP获悉，微创机器人-B(02252)再涨超7%，截至发稿，涨6.53%，报18.28港元，成交额9061.66万港元。
消息面上，微创机器人发布公告，集团自主研发的图迈单臂单孔腔镜手术机器人(图迈单臂)获得国家药品监督管理局的注册批准，表明其整体性能、创新水平及临床有效性、安全性已获得国家权威监管部门认证。
西部证券指出，公司“五分之四”机器人版图已成，2025-2026年将是重要扭亏节点；国内配置证政策放松带来市场扩容，2023年6月新版医用设备配置证中腹腔内窥镜手术机器人规划数新增215%，公司订单量连续2年实现翻倍以上增长；海外市场快速突破，商业化首年即获批20+海外订单，5G远程手术方案助力学术推广和装机入院。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.